PRKDC and neoplasm: Finally, immunohistochemical staining of orthotopic xenograft tumours confirmed that DNA-PK is phosphorylated and activated in response to AZD1775 and AZD1775 + AZD6738 combination treatment in vivo (Figure 4—figure supplement 2C).